AU2013209620B2 - Chromatographic media for storage and delivery of therapeutic biologics and small molecules - Google Patents

Chromatographic media for storage and delivery of therapeutic biologics and small molecules Download PDF

Info

Publication number
AU2013209620B2
AU2013209620B2 AU2013209620A AU2013209620A AU2013209620B2 AU 2013209620 B2 AU2013209620 B2 AU 2013209620B2 AU 2013209620 A AU2013209620 A AU 2013209620A AU 2013209620 A AU2013209620 A AU 2013209620A AU 2013209620 B2 AU2013209620 B2 AU 2013209620B2
Authority
AU
Australia
Prior art keywords
certain embodiments
composite material
relates
stabilizing agent
composite materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2013209620A
Other languages
English (en)
Other versions
AU2013209620A1 (en
Inventor
John A. Chickosky
Charles H. Honeyman
Molly S. Mcglaughlin
Amro Ragheb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Millipore Ltd
Original Assignee
Merck Millipore Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Millipore Ltd filed Critical Merck Millipore Ltd
Publication of AU2013209620A1 publication Critical patent/AU2013209620A1/en
Application granted granted Critical
Publication of AU2013209620B2 publication Critical patent/AU2013209620B2/en
Assigned to MERCK MILLIPORE LTD. reassignment MERCK MILLIPORE LTD. Request for Assignment Assignors: NATRIX SEPARATIONS INC.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2013209620A 2012-01-19 2013-01-18 Chromatographic media for storage and delivery of therapeutic biologics and small molecules Active AU2013209620B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261588312P 2012-01-19 2012-01-19
US61/588,312 2012-01-19
PCT/US2013/022057 WO2013109825A1 (en) 2012-01-19 2013-01-18 Chromatographic media for storage and delivery of therapeutic biologics and small molecules

Publications (2)

Publication Number Publication Date
AU2013209620A1 AU2013209620A1 (en) 2014-08-28
AU2013209620B2 true AU2013209620B2 (en) 2017-06-15

Family

ID=48797397

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013209620A Active AU2013209620B2 (en) 2012-01-19 2013-01-18 Chromatographic media for storage and delivery of therapeutic biologics and small molecules

Country Status (10)

Country Link
US (2) US20130189322A1 (enExample)
EP (1) EP2804634B1 (enExample)
JP (2) JP6552822B2 (enExample)
KR (1) KR102113296B1 (enExample)
AU (1) AU2013209620B2 (enExample)
CA (2) CA2861932C (enExample)
DK (1) DK2804634T3 (enExample)
ES (1) ES2750211T3 (enExample)
IN (1) IN2014DN06817A (enExample)
WO (1) WO2013109825A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015005937A2 (pt) 2012-09-17 2017-07-04 Grace W R & Co meios e dispositivos cromatográficos
EP3024843B1 (en) 2013-07-25 2022-08-31 Bio-Rad Laboratories, Inc. Enhanced functionality and delivery of a protein from a porous substrate
FR3012978A1 (fr) * 2013-11-12 2015-05-15 Biocarecell Filtre biocompatible et procede de fabrication d'un filtre biocompatible.
ES2887110T3 (es) 2014-01-16 2021-12-21 Grace W R & Co Medios para cromatografía de afinidad y dispositivos para cromatografía
US11389783B2 (en) 2014-05-02 2022-07-19 W.R. Grace & Co.-Conn. Functionalized support material and methods of making and using functionalized support material
IS3008B (is) * 2014-05-14 2018-12-15 Calor ehf Stöðgandi lausnir fyrir prótín og peptíð
PL3302784T3 (pl) 2015-06-05 2022-01-17 W.R. Grace & Co.-Conn. Adsorbentowe środki klarujące do bioprzetwarzania oraz sposoby ich wytwarzania i stosowania
BR112020021134A2 (pt) * 2018-04-16 2021-03-23 Merck Patent Gmbh aditivos para formulações de proteínas para aprimorar estabilidade térmica

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090029438A1 (en) * 2003-02-19 2009-01-29 Childs Ronald F Composite materials comprising supported porous gels
US20100178210A1 (en) * 2004-05-24 2010-07-15 Genvault Corporation Stable protein storage and stable nucleic acid storage in recoverable form

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059654A (en) * 1983-02-14 1991-10-22 Cuno Inc. Affinity matrices of modified polysaccharide supports
DE229810T1 (de) * 1985-07-09 1987-11-05 Quadrant Bioresources Ltd., Soulbury, Leighton Buzzard, Bedfordshire Beschuetzung von proteinen und aehnlichem.
EP0513332A4 (en) * 1990-11-14 1993-03-17 Cargill, Incorporated Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins
US5159049A (en) * 1991-04-22 1992-10-27 Allen Robert C Method for stabilizing polyacrylamide gels
US5583162A (en) * 1994-06-06 1996-12-10 Biopore Corporation Polymeric microbeads and method of preparation
US6284282B1 (en) * 1998-04-29 2001-09-04 Genentech, Inc. Method of spray freeze drying proteins for pharmaceutical administration
SE9904475D0 (sv) * 1999-12-08 1999-12-08 Artursson Nucleic acid delivery system
US6896894B2 (en) * 2001-10-30 2005-05-24 Battelle Memorial Institute Proteins stabilized with polysaccharide gums
JP2005517012A (ja) * 2002-02-08 2005-06-09 アルカーメス コントロールド セラピューティクス，インコーポレイテッド 持続放出のためのポリマーベース組成物
US20040137004A1 (en) * 2002-03-19 2004-07-15 Glenn Gregory M Patch for transcutaneous immunization
US6666281B2 (en) 2002-03-19 2003-12-23 Deere & Company Bearing guard for a ground-working implement
US7785769B2 (en) * 2003-07-25 2010-08-31 The United States of America as reprsented by the Secretary of the Navy Immobilization of oligonucleotides and proteins in sugar-containing hydrogels
CA2558859C (en) 2004-04-08 2014-02-04 Mcmaster University Membrane stacks
EP1773485B1 (en) * 2004-06-07 2015-09-16 Natrix Separations Inc. Stable composite material comprising supported porous gels

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090029438A1 (en) * 2003-02-19 2009-01-29 Childs Ronald F Composite materials comprising supported porous gels
US20100178210A1 (en) * 2004-05-24 2010-07-15 Genvault Corporation Stable protein storage and stable nucleic acid storage in recoverable form

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KANANI et al., "Separation of human plasma proteins HSA and HIgG using high-capacity macroporous gel-filled membranes", Biochemical Engineering Journal, 2007, vol 35, pages 295-300 *

Also Published As

Publication number Publication date
EP2804634A1 (en) 2014-11-26
AU2013209620A1 (en) 2014-08-28
DK2804634T3 (da) 2019-11-04
US20130189322A1 (en) 2013-07-25
WO2013109825A1 (en) 2013-07-25
JP2015504092A (ja) 2015-02-05
CA3124806C (en) 2023-09-26
JP2019011341A (ja) 2019-01-24
CA3124806A1 (en) 2013-07-27
ES2750211T3 (es) 2020-03-25
KR20140117529A (ko) 2014-10-07
EP2804634A4 (en) 2015-07-22
CA2861932C (en) 2021-09-14
IN2014DN06817A (enExample) 2015-05-22
KR102113296B1 (ko) 2020-06-02
JP6552822B2 (ja) 2019-07-31
US20200069602A1 (en) 2020-03-05
CA2861932A1 (en) 2013-07-27
EP2804634B1 (en) 2019-08-28

Similar Documents

Publication Publication Date Title
US20200069602A1 (en) Chromatographic media for storage and delivery of therapeutic biologics and small molecules
ES2811137T3 (es) Membranas para cromatografía formadas por reacciones de polimerización clic de tiol-eno o tiol-ino
JP6082903B2 (ja) 創傷環境における治療因子の結合のためのアプタマー変性高分子材料
EP1617936B1 (en) Composite materials comprising supported porous gels
ES2912930T3 (es) Membranas de cromatografía en modo mixto
AU2010317563B2 (en) Hydrophobic interaction chromatography membranes, and methods of use thereof
US20100273991A1 (en) Method of covalently modifying proteins with organic molecules to prevent aggregation
US20220410076A1 (en) Methods for coupling a ligand to a composite material
US20140273158A1 (en) Chromatography Membranes Stable Under Caustic Conditions
JP7609853B2 (ja) クロマトグラフィー媒体の超臨界乾燥
Zhang et al. Temperature responsive pore‐filled membranes based on a BSA/poly (N‐isopropylacrylamide) hydrogel
Gonçalves Porous Structures for the Purification of Biopharmaceuticals

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: MERCK MILLIPORE LTD.

Free format text: FORMER OWNER(S): NATRIX SEPARATIONS INC.